Medicover AB
STO:MCOV B
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
121.0097
204
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MCOV B stock under the Base Case scenario is 274.37 SEK. Compared to the current market price of 191.6 SEK, Medicover AB is Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medicover AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MCOV B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medicover AB
Balance Sheet Decomposition
Medicover AB
Current Assets | 425.6m |
Cash & Short-Term Investments | 88.7m |
Receivables | 270.7m |
Other Current Assets | 66.2m |
Non-Current Assets | 1.6B |
Long-Term Investments | 19.6m |
PP&E | 908m |
Intangibles | 653.8m |
Other Non-Current Assets | 30.6m |
Current Liabilities | 534.2m |
Accounts Payable | 217.8m |
Other Current Liabilities | 316.4m |
Non-Current Liabilities | 1B |
Long-Term Debt | 888m |
Other Non-Current Liabilities | 115.5m |
Earnings Waterfall
Medicover AB
Revenue
|
1.9B
EUR
|
Cost of Revenue
|
-1.5B
EUR
|
Gross Profit
|
394.7m
EUR
|
Operating Expenses
|
-316.9m
EUR
|
Operating Income
|
77.8m
EUR
|
Other Expenses
|
-54.7m
EUR
|
Net Income
|
23.1m
EUR
|
Free Cash Flow Analysis
Medicover AB
EUR | |
Free Cash Flow | EUR |
In the second quarter, the company experienced robust organic revenue growth of 16.5%, contributing to a 20% overall increase. Poland and Germany led this growth, with revenues rising by 24% and 18% respectively. Operating leverage saw significant improvements, with EBITDA up 22%, EBITDAaL up 28%, and operating profit soaring by 45%. The company reaffirmed its confident outlook, projecting organic revenues to reach EUR 2.2 billion by 2025. Despite some challenges in the Indian market and recent hospital openings, overall financial targets remain well on track, supported by strong cash generation and prudent capital expenditure, now at 5% of revenue.
What is Earnings Call?
MCOV B Profitability Score
Profitability Due Diligence
Medicover AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Medicover AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
MCOV B Solvency Score
Solvency Due Diligence
Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MCOV B Price Targets Summary
Medicover AB
Dividends
Current shareholder yield for MCOV B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 38,555 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Contact
IPO
Employees
Officers
The intrinsic value of one MCOV B stock under the Base Case scenario is 274.37 SEK.
Compared to the current market price of 191.6 SEK, Medicover AB is Undervalued by 30%.